Cutler Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-700
| Closed | -$2K | – | 2563 |
|
|
2018
Q1 | $2K | Sell |
700
-3,400
| -83% | -$9.71K | ﹤0.01% | 1686 |
|
|
2017
Q4 | $19K | Buy |
4,100
+3,120
| +318% | +$14.5K | ﹤0.01% | 1417 |
|
|
2017
Q3 | $6K | Buy |
980
+244
| +33% | +$1.49K | ﹤0.01% | 2091 |
|
|
2017
Q2 | $5K | Buy |
+736
| New | +$5K | ﹤0.01% | 2427 |
|
|
2017
Q1 | – | Sell |
-1,205
| Closed | -$7K | – | 3653 |
|
|
2016
Q4 | $7K | Sell |
1,205
-3,709
| -75% | -$21.5K | ﹤0.01% | 2404 |
|
|
2016
Q3 | $26K | Buy |
4,914
+4,400
| +856% | +$23.3K | ﹤0.01% | 1735 |
|
|
2016
Q2 | $3K | Hold |
514
| – | – | ﹤0.01% | 2555 |
|
|
2016
Q1 | $2K | Sell |
514
-5,788
| -92% | -$22.5K | ﹤0.01% | 2625 |
|
|
2015
Q4 | $31K | Buy |
+6,302
| New | +$31K | ﹤0.01% | 1650 |
|